Vivos Therapeutics, Inc.VVOSNASDAQ
Loading
PB Ratio: Discounted ValuationCompressed
Percentile Rank50
3Y CAGR+13.1%
Studio
Year-over-Year Change

Price-to-book ratio

3Y CAGR
+13.1%/yr
Annual compound
Percentile
P50
Within normal range
vs 3Y Ago
1.4x
Solid growth
Streak
1 yr
Consecutive declineCompressed
PeriodValueYoY Change
20242.71-92.7%
202336.91+1815.4%
20221.93+3.0%
20211.87-70.6%
20206.36+116.8%
2019-37.91-276.3%
201821.51-